Pneumococcal disease is a deadly infectious disease that kills 1.6 million people each year, including 800,000 children under age five. Global awareness of this deadly disease, however, remains low. Sabin convenes the world’s leading experts in epidemiology and other key public health professionals at regional and country-level symposia, including the Regional Pneumococcal Symposium. Developed in collaboration with the World Health Organization (WHO), the Pan American Health Organization (PAHO), the U.S. Centers for Disease Control and Prevention, and PneumoADIP, the regional symposia provide a forum to share the latest pneumococcal research and new prevention strategies.

The Fifth Regional Pneumococcal Symposium was held 5-6 March, 2013 in São Paulo, Brazil. It brought together 160 stakeholders from 26 countries to discuss updates on epidemiological and economic data in order to inform public health agendas related to prevention of pneumococcal disease in older children and adults in Latin America and the Caribbean.

You can find more information here, and the agenda and presentations here.

Held in Johannesburg, South Africa on March 2-3, 2009, the Fourth Regional Pneumococcal Symposium brought together over 185 scientific experts, key decision makers and public health professionals from 38 countries around the world who have dedicated their efforts to pneumococcal vaccine development and control of pneumococcal disease. While in Johannesburg, experts reviewed progress toward safe, effective pneumococcal vaccines and addressed many questions, including how to make sure they get to the world's poorest children.

You can find more information here and the proceedings here.

The 3rd Regional Pneumococcal Symposium held in Istanbul, Turkey on February 13-14, 2008, brought together 200 participants from Bulgaria, Greece, Kazakhstan, Kyrgyzstan, Romania, Tajikistan, Turkey, Turkmenistan, and Uzbekistan, as well as officials from the World Health Organization (WHO) and representatives from multilateral agencies and pharmaceutical companies, to discuss the latest advances of pneumococcal vaccines. The objective of the meeting was to review the substantial progress made in two years toward safe, effective vaccines and to address the challenge of ensuring that they get to the world’s poorest children. The Symposium reviewed advances in the scientific leadership emerging in country after country that is building a global movement for pneumococcal prevention—one revolving around adoption of new and highly effective vaccines—that is increasingly hard to ignore.

You can find more information here and the meeting report here.